• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回肠克罗恩病中基质细胞与髓样细胞的相互作用全景;成纤维细胞衍生的CCL-2发挥重要作用的迹象

Landscape of Interactions between Stromal and Myeloid Cells in Ileal Crohn's Disease; Indications of an Important Role for Fibroblast-Derived CCL-2.

作者信息

Dovrolis Nikolas, Valatas Vassilis, Drygiannakis Ioannis, Filidou Eirini, Spathakis Michail, Kandilogiannakis Leonidas, Tarapatzi Gesthimani, Arvanitidis Konstantinos, Bamias Giorgos, Vradelis Stergios, Manolopoulos Vangelis G, Paspaliaris Vasilis, Kolios George

机构信息

Laboratory of Pharmacology, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.

Individualised Medicine & Pharmacological Research Solutions Center (IMPReS), 68100 Alexandroupolis, Greece.

出版信息

Biomedicines. 2024 Jul 26;12(8):1674. doi: 10.3390/biomedicines12081674.

DOI:10.3390/biomedicines12081674
PMID:39200138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11351973/
Abstract

BACKGROUND AND AIMS

Monocyte recruitment in the lamina propria and inflammatory phenotype driven by the mucosal microenvironment is critical for the pathogenesis of inflammatory bowel disease. However, the stimuli responsible remain largely unknown. Recent works have focused on stromal cells, the main steady-state cellular component in tissue, as they produce pro-inflammatory chemokines that contribute to the treatment-resistant nature of IBD.

METHODS

We studied the regulation of these processes by examining the communication patterns between stromal and myeloid cells in ileal Crohn's disease (CD) using a complete single-cell whole tissue sequencing analysis pipeline and in vitro experimentation in mesenchymal cells.

RESULTS

We report expansion of S4 stromal cells and monocyte-like inflammatory macrophages in the inflamed mucosa and describe interactions that may establish sustained local inflammation. These include expression of CCL2 by S1 fibroblasts to recruit and retain monocytes and macrophages in the mucosa, where they receive signals for proliferation, survival, and differentiation to inflammatory macrophages from S4 stromal cells through molecules such as MIF, IFNγ, and FN1. The overexpression of CCL2 in ileal CD and its stromal origin was further demonstrated in vitro by cultured mesenchymal cells and intestinal organoids in the context of an inflammatory milieu.

CONCLUSIONS

Our findings outline an extensive cross-talk between stromal and myeloid cells, which may contribute to the onset and progression of inflammation in ileal Crohn's disease. Understanding the mechanisms underlying monocyte recruitment and polarization, as well as the role of stromal cells in sustaining inflammation, can provide new avenues for developing targeted therapies to treat IBD.

摘要

背景与目的

固有层中的单核细胞募集以及由黏膜微环境驱动的炎症表型对于炎症性肠病的发病机制至关重要。然而,引发这些反应的刺激因素在很大程度上仍不清楚。近期的研究聚焦于基质细胞,它是组织中主要的稳态细胞成分,因为它们会产生促炎趋化因子,这促成了炎症性肠病难治的特性。

方法

我们通过使用完整的单细胞全组织测序分析流程研究回肠克罗恩病(CD)中基质细胞与髓样细胞之间的通讯模式,并在间充质细胞中进行体外实验,来探究这些过程的调控机制。

结果

我们报告了在炎症黏膜中S4基质细胞和单核细胞样炎性巨噬细胞的扩增,并描述了可能导致持续性局部炎症的相互作用。这些相互作用包括S1成纤维细胞表达CCL2以在黏膜中募集和保留单核细胞和巨噬细胞,在黏膜中它们通过MIF、IFNγ和FN1等分子从S4基质细胞接收增殖、存活和分化为炎性巨噬细胞的信号。在炎性环境中,培养的间充质细胞和肠类器官在体外进一步证实了回肠CD中CCL2的过表达及其基质来源。

结论

我们的研究结果概述了基质细胞与髓样细胞之间广泛的相互作用,这可能促成回肠克罗恩病炎症的发生和进展。了解单核细胞募集和极化的潜在机制,以及基质细胞在维持炎症中的作用,可为开发治疗炎症性肠病的靶向疗法提供新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/fc2c36f3b62a/biomedicines-12-01674-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/de3662c797a0/biomedicines-12-01674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/1ebf3729e071/biomedicines-12-01674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/b6ba759e2076/biomedicines-12-01674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/78dc9dae0ff3/biomedicines-12-01674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/341b7f3dfe1f/biomedicines-12-01674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/9691a8e10b5f/biomedicines-12-01674-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/b8dc1fd6bc97/biomedicines-12-01674-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/71d730be4478/biomedicines-12-01674-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/771bcfafe4c6/biomedicines-12-01674-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/b145a98d6b17/biomedicines-12-01674-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/1534a37a8ad3/biomedicines-12-01674-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/de63001c17aa/biomedicines-12-01674-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/fc2c36f3b62a/biomedicines-12-01674-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/de3662c797a0/biomedicines-12-01674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/1ebf3729e071/biomedicines-12-01674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/b6ba759e2076/biomedicines-12-01674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/78dc9dae0ff3/biomedicines-12-01674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/341b7f3dfe1f/biomedicines-12-01674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/9691a8e10b5f/biomedicines-12-01674-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/b8dc1fd6bc97/biomedicines-12-01674-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/71d730be4478/biomedicines-12-01674-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/771bcfafe4c6/biomedicines-12-01674-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/b145a98d6b17/biomedicines-12-01674-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/1534a37a8ad3/biomedicines-12-01674-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/de63001c17aa/biomedicines-12-01674-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efd6/11351973/fc2c36f3b62a/biomedicines-12-01674-g013.jpg

相似文献

1
Landscape of Interactions between Stromal and Myeloid Cells in Ileal Crohn's Disease; Indications of an Important Role for Fibroblast-Derived CCL-2.回肠克罗恩病中基质细胞与髓样细胞的相互作用全景;成纤维细胞衍生的CCL-2发挥重要作用的迹象
Biomedicines. 2024 Jul 26;12(8):1674. doi: 10.3390/biomedicines12081674.
2
Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.克罗恩病患者肠道固有层中 CD14+CD163low 髓系细胞诱导 Th17 活性增强。
Gastroenterology. 2013 Dec;145(6):1380-91.e1. doi: 10.1053/j.gastro.2013.08.049. Epub 2013 Aug 29.
3
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease.炎症中肠基质细胞的紊乱和炎症性肠病中结缔组织修复缺陷。
Inflamm Bowel Dis. 2024 Sep 3;30(9):1604-1618. doi: 10.1093/ibd/izae066.
4
Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn's Disease: A Cohort Study.新发回肠结肠克罗恩病的固有免疫激活:一项队列研究。
Dis Colon Rectum. 2024 May 1;67(5):681-692. doi: 10.1097/DCR.0000000000003145. Epub 2024 Feb 6.
5
Expression of Programmed Death-Ligand 1 by Human Colonic CD90 Stromal Cells Differs Between Ulcerative Colitis and Crohn's Disease and Determines Their Capacity to Suppress Th1 Cells.人结直肠 CD90 基质细胞程序性死亡配体 1 的表达在溃疡性结肠炎和克罗恩病之间存在差异,并决定其抑制 Th1 细胞的能力。
Front Immunol. 2018 May 30;9:1125. doi: 10.3389/fimmu.2018.01125. eCollection 2018.
6
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
7
TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease Patients.TREM-1+ 巨噬细胞在克罗恩病患者的肠道中定义了一个致病细胞亚群。
J Crohns Colitis. 2021 Aug 2;15(8):1346-1361. doi: 10.1093/ecco-jcc/jjab022.
8
Platelet-Rich stroma from Crohn's disease patients for treatment of perianal fistula shows a higher myeloid cell profile compared to non-IBD controls.与非炎症性肠病(IBD)对照相比,来自克罗恩病患者用于治疗肛周瘘的富含血小板的基质显示出更高的髓样细胞特征。
Stem Cell Res. 2023 Mar;67:103039. doi: 10.1016/j.scr.2023.103039. Epub 2023 Feb 2.
9
CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.炎症性肠病中血液树突状细胞上CD40和CD86上调且CMRF44表达存在差异
Am J Gastroenterol. 2001 Oct;96(10):2946-56. doi: 10.1111/j.1572-0241.2001.04686.x.
10
Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.间充质基质细胞治疗克罗恩病的进展。
Expert Rev Gastroenterol Hepatol. 2018 Feb;12(2):141-153. doi: 10.1080/17474124.2018.1393332. Epub 2017 Nov 2.

本文引用的文献

1
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease.炎症中肠基质细胞的紊乱和炎症性肠病中结缔组织修复缺陷。
Inflamm Bowel Dis. 2024 Sep 3;30(9):1604-1618. doi: 10.1093/ibd/izae066.
2
Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study.炎症细胞因子与炎症性肠病的关联:一项孟德尔随机化研究。
Front Immunol. 2024 Jan 15;14:1327879. doi: 10.3389/fimmu.2023.1327879. eCollection 2023.
3
Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosis.
社论:肠道炎症和纤维化中的基质细胞与免疫细胞相互作用
Front Immunol. 2023 Feb 16;14:1152140. doi: 10.3389/fimmu.2023.1152140. eCollection 2023.
4
Understanding disruption of the gut barrier during inflammation: Should we abandon traditional epithelial cell lines and switch to intestinal organoids?理解炎症期间肠道屏障的破坏:我们是否应该放弃传统的上皮细胞系,转而使用肠道类器官?
Front Immunol. 2023 Feb 16;14:1108289. doi: 10.3389/fimmu.2023.1108289. eCollection 2023.
5
The Application of Single-Cell RNA Sequencing in the Inflammatory Tumor Microenvironment.单细胞 RNA 测序在炎症肿瘤微环境中的应用。
Biomolecules. 2023 Feb 10;13(2):344. doi: 10.3390/biom13020344.
6
Pretreatment serum monocyte chemoattractant protein-1 as a predictor of long-term outcome by ustekinumab in patients with Crohn's disease.预处理血清单核细胞趋化蛋白-1 可预测乌司奴单抗治疗克罗恩病患者的长期结局。
J Gastroenterol Hepatol. 2023 Jun;38(6):910-920. doi: 10.1111/jgh.16151. Epub 2023 Mar 8.
7
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?炎症性肠病中纤维化基因的共表达;局部事件?
Front Immunol. 2022 Dec 23;13:1058237. doi: 10.3389/fimmu.2022.1058237. eCollection 2022.
8
Crosstalk between myofibroblasts and macrophages: A regulative factor of valvular fibrosis in calcific aortic valve disease.成纤维细胞与巨噬细胞的串扰:钙化性主动脉瓣疾病中瓣膜纤维化的调节因子。
Cell Biol Int. 2023 Apr;47(4):754-767. doi: 10.1002/cbin.11980. Epub 2022 Dec 21.
9
Immune niches orchestrated by intestinal mesenchymal stromal cells lining the crypt-villus.肠道隐窝-绒毛间充质基质细胞构成的免疫生态位
Front Immunol. 2022 Nov 3;13:1057932. doi: 10.3389/fimmu.2022.1057932. eCollection 2022.
10
The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial Myofibroblasts.益生菌菌株乳酸双歧杆菌、嗜酸乳杆菌、植物乳杆菌和布拉氏酵母菌可调节人肠上皮下肌成纤维细胞的伤口愈合和趋化因子反应。
Pharmaceuticals (Basel). 2022 Oct 20;15(10):1293. doi: 10.3390/ph15101293.